¡i©ú³ø±M°T¡j¶Â²ù¤½¥q(BlackBerry)ªÑ»ù¦A¶Ç±¶³ø¡A ©P¥|¤W¤È¦b¦hÛ¦hÃÒ¥æ©Ò¤@«×²rº¦ªñ11%¡A¦¬¥«ºû«ù7.98%¼W´T¡C¶Â²ù¨ÎÁZ¤S¤W¼h¼Ó¡AÂk¦]©ó¤@¥÷¬ã¨s³ø§i°Û¦n¨ä«e´º¡A»{¬°¥¦¥i¯à¦¨¬°¦¬ÁʥؼСC
¶Â²ùªÑ»ù©P¥|¤@«×¤É¦Ü15.82¤¸¡A¼W´T10.78%¡C³Ì²×¦¬³ø15.42¤¸¡A¤É1.14¤¸¡A©Î7.98%¡C
¦«e¤w¦³Åv«Â¬ü°ê§ë¸ê¾÷ºc¹w´ú¡A³o¶¡¥[®³¤j¬ì§Þ¤½¥qªºªÑ»ùÀ³·|¥[¿¡A·½¦Û¼Æ¦~§áÂàÀZ¶Õªº±¹¬I¶}©l×±o¥¿ªG¡C
¶Â²ùªÑ²¼¹L¥h2Ӥ뺦´T±Nªñ70%¡A¥¦»P¨T¨®¼t¤Î¨ä¥L¥ø·~¦¨¥\ñ¬ù¡A§ë¸ê¤H¹ï¤½¥q«e´º«H¤ß¤j©ô¡C
¬ü°êªfªÅ¬ã¨s¾÷ºc»òX(Citron Research)©P¥|³ø§i»¡¡A¥¦¹w®Æ¶Â²ù¶ÕÀYÄ~Äò¨«°ª¡C
¸Ó¾÷ºc¥ÑµÜ¤Ò¯S(Andrew Left)»â¾É¡A¬Æ¤Ö°Û¦nªÑ²¼¡A¥¦¥´ÅTª¾¦W«×¡A¬O¦]¾÷ºcµo¥¬§K¶O³ø§i¡A©ÜÅS¥¦»{¬°³Q°ª¦ô©Î¯A¶B´Ûªº¤½¥q¡C
»òX2015¦~²v¥ý´¦µo¡A¥[®³¤j»sÃÄ°ÓValeant Pharmaceuticals International Inc.³z¹L¦³ÃöÁpªºÂåÃĺ޹D¯B³ø¦¬¤J¡A«P¨Ï¸Ó¤½¥q§ï²¸gÀç¼Ò¦¡¡C
¶Â²ù©ñ±ó¦«e«ÂI¾P°â¦Û®a¤â¾÷ªº¸gÀç¼Ò¦¡¡AÂà¦V¾P°â³n¥ó¡A¥Î©ó¥[±K²¾°Ê³]³Æ¤Î¨T¨®¡A¥H¤Îºôµ¸«O¦wÅU°ÝªA°È¡C
»òX»¡¡A¥¦¬Ý¦n¶Â²ùQNX¨T¨®¹q¸£¾Þ§@¨t²Îªº¾P°â«e´º¡C
¶Â²ùªºQNX¤w¦w¸Ë¦b¹O6,000¸U½ø©Ð¨®¤W¡A¥Î©ó¾Þ§@¸ê°T®T¼Ö¤Î¨®½ø»·µ{±±¨î»P«H®§¨t²Î¡C»òX»¡¡A³o»·¶W1,600¸U½ø¨T¨®¦w¸ËªºMobileye¨t²Î¡A¨º¬O¤@¶¡¦Û°Ê¾r¾p¨T¨®¬ì§Þ¤½¥q¡A´¹¤ù¥¨À¼Intel Corp.¤µ¦~3¤ëºÙ·|¥H153»õ¤¸¦¬ÁʸӤ½¥q¡C
¶Â²ù§Æ±æ§Q¥ÎÀu¶Õ¦A¤W°ª®p¡Aűo§ó¦h¨®¼t«C·ý¡Aª½±µ¯A¤Î¦Û°Ê¾r¾p¬ì§Þ·~°È¡C
¶Â²ùªºQNX³¡ªù10¤ëªí¥Ü¡A¥¦Áp¤âºÖ¯S¨T¨®¤½¥q¡A¸Ó¨®¼t¦b¥[±j¦Û°Ê¤Æ¨T¨®¬ãµo¡C¶Â²ù¦æ¬F¤Hû¥ç»¡¡A¥LÌ¥¿¦b»P¦hÓ¨ä¥L¥Dn¥þ²y¨T¨®¼t¡A°Ó½ÍÃþ¦üªº¦X§@¡C
ª÷¿Ä§ë¸ê¤½¥q³Á®æ²z¶°¹Î(Macquarie Group)ªº¤@¦W¤ÀªRû¤W¤ë»¡¡A¶Â²ù¦Ü¤Ö¦b»P¨â®a¨®¼t¦X§@¡A¶}µo«O¦wªA°È¡A¥Î©ó»·¶Z±½´y¨®½ø°»´ú¹q¸£¯f¬r¡Aĵ§i¥q¾÷¤Î®É°±¨®¡AÁ׶}ÄY«¦MÀI¡C